1.
Tha?i D, Blauvelt A, Reich K, Warren R, Piguet V, Brock F, Fierens F, Ciaravino V, Lebwohl M. Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. J of Skin [Internet]. 2021Jan.1 [cited 2024Jul.3];5(1):s20. Available from: https://jofskin.org/index.php/skin/article/view/1173